131 related articles for article (PubMed ID: 33867228)
21. Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.
Feldman A; Eder SK; Felder TK; Kedenko L; Paulweber B; Stadlmayr A; Huber-Schönauer U; Niederseer D; Stickel F; Auer S; Haschke-Becher E; Patsch W; Datz C; Aigner E
Am J Gastroenterol; 2017 Jan; 112(1):102-110. PubMed ID: 27527746
[TBL] [Abstract][Full Text] [Related]
22. 13C-methacetin breath test shortened: 2-point-measurements after 15 minutes reliably indicate the presence of liver cirrhosis.
Schneider A; Caspary WF; Saich R; Dietrich CF; Sarrazin C; Kuker W; Braden B
J Clin Gastroenterol; 2007 Jan; 41(1):33-7. PubMed ID: 17198062
[TBL] [Abstract][Full Text] [Related]
23. Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery.
Argentou M; Tiniakos DG; Karanikolas M; Melachrinou M; Makri MG; Kittas C; Kalfarentzos F
Obes Surg; 2009 Sep; 19(9):1313-23. PubMed ID: 19693638
[TBL] [Abstract][Full Text] [Related]
24. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.
Hohenester S; Christiansen S; Nagel J; Wimmer R; Artmann R; Denk G; Bischoff M; Bischoff G; Rust C
Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G329-G338. PubMed ID: 29878845
[TBL] [Abstract][Full Text] [Related]
25. 13C-methacetin breath test: isotope-selective nondispersive infrared spectrometry in comparison to isotope ratio mass spectrometry in volunteers and patients with liver cirrhosis.
Adamek RJ; Goetze O; Boedeker C; Pfaffenbach B; Luypaerts A; Geypens B
Z Gastroenterol; 1999 Dec; 37(12):1139-43. PubMed ID: 10666836
[TBL] [Abstract][Full Text] [Related]
26. FAT AND MUSCLE COMPONENTS OF BODY WEIGHT AND THEIR RELATIONSHIP WITH THE CONCENTRATION OF SERUM ADIPOKINES IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
Pivtorak K; Fedzhaga I; Pivtorak N; Vozniuk L; Klekot O
Wiad Lek; 2022; 75(5 pt 2):1289-1294. PubMed ID: 35758445
[TBL] [Abstract][Full Text] [Related]
27. Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels.
Festi D; Capodicasa S; Sandri L; Colaiocco-Ferrante L; Staniscia T; Vitacolonna E; Vestito A; Simoni P; Mazzella G; Portincasa P; Roda E; Colecchia A
World J Gastroenterol; 2005 Jan; 11(1):142-8. PubMed ID: 15609414
[TBL] [Abstract][Full Text] [Related]
28. 13C-phenylalanine and 13C-methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver disease.
Lara Baruque S; Razquin M; Jimenez I; Vazquez A; Gisbert JP; Pajares JM
Dig Liver Dis; 2000 Apr; 32(3):226-32. PubMed ID: 10975773
[TBL] [Abstract][Full Text] [Related]
29. [The value of studying liver function reserve in hepatic carcinoma by 13C-methacetin breath test].
Li HX; Wang JP; Yang Y; Zhang J; Feng QL
Zhonghua Nei Ke Za Zhi; 2009 May; 48(5):383-7. PubMed ID: 19615155
[TBL] [Abstract][Full Text] [Related]
30. 13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection.
Braden B; Faust D; Sarrazin U; Zeuzem S; Dietrich CF; Caspary WF; Sarrazin C
Aliment Pharmacol Ther; 2005 Jan; 21(2):179-85. PubMed ID: 15679768
[TBL] [Abstract][Full Text] [Related]
31. Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease.
Oh S; Tanaka K; Tsujimoto T; So R; Shida T; Shoda J
Metab Syndr Relat Disord; 2014 Jun; 12(5):290-8. PubMed ID: 24689911
[TBL] [Abstract][Full Text] [Related]
32. What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?
Machado MV; Policarpo S; Coutinho J; Carvalhana S; Leitão J; Carvalho A; Silva AP; Velasco F; Medeiros I; Alves AC; Bourbon M; Cortez-Pinto H
Obes Surg; 2020 Feb; 30(2):560-568. PubMed ID: 31637670
[TBL] [Abstract][Full Text] [Related]
33. [The 13C-methacetin breath test for quantitative noninvasive liver function analysis with an isotope-specific nondispersive infrared spectrometer in liver cirrhosis].
Pfaffenbach B; Götze O; Szymanski C; Hagemann D; Adamek RJ
Dtsch Med Wochenschr; 1998 Dec; 123(49):1467-71. PubMed ID: 9861887
[TBL] [Abstract][Full Text] [Related]
34. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease.
Sayın O; Tokgöz Y; Arslan N
J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600
[TBL] [Abstract][Full Text] [Related]
35. What is the role of adiponectin in obesity related non-alcoholic fatty liver disease?
Finelli C; Tarantino G
World J Gastroenterol; 2013 Feb; 19(6):802-12. PubMed ID: 23430039
[TBL] [Abstract][Full Text] [Related]
36. Clinical and metabolic characterization of obese subjects without non-alcoholic fatty liver: A targeted metabolomics approach.
Feldman A; Eder SK; Felder TK; Paulweber B; Zandanell S; Stechemesser L; Schranz M; Strebinger G; Huber-Schönauer U; Niederseer D; Patsch W; Weghuber D; Tevini J; Datz C; Aigner E
Diabetes Metab; 2019 Apr; 45(2):132-139. PubMed ID: 30266576
[TBL] [Abstract][Full Text] [Related]
37. Response of fibroblast growth factor 19 and bile acid synthesis after a body weight-adjusted oral fat tolerance test in overweight and obese NAFLD patients: a non-randomized controlled pilot trial.
Friedrich D; Marschall HU; Lammert F
BMC Gastroenterol; 2018 Jun; 18(1):76. PubMed ID: 29866129
[TBL] [Abstract][Full Text] [Related]
38. Low levels of total and high-molecular-weight adiponectin may predict non-alcoholic fatty liver in Korean adults.
Kim YS; Lee SH; Park SG; Won BY; Chun H; Cho DY; Kim MJ; Lee JE; Haam JH; Han K
Metabolism; 2020 Feb; 103():154026. PubMed ID: 31765666
[TBL] [Abstract][Full Text] [Related]
39. [Abdominal adipose area, serum adiponectin and leptin levels of nonalcoholic fatty liver disease in elderly males.].
Tao T; Wu L; Shen BB; Zhao YJ
Zhonghua Gan Zang Bing Za Zhi; 2009 Feb; 17(2):120-3. PubMed ID: 19254460
[TBL] [Abstract][Full Text] [Related]
40. Leptin-to-adiponectin ratio in obese adolescents with nonalcoholic fatty liver disease.
Angın Y; Arslan N; Kuralay F
Turk J Pediatr; 2014; 56(3):259-66. PubMed ID: 25341597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
